Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

(2020) Syed Faraz Ahmed et al.   Viruses-Basel

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

(2020) Qihui Wang et al.   CELL

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

(2020) Alba Grifoni et al.   CELL

Whole nucleocapsid protein of SARS-CoV-2 may cause false positive results in serological assays

(2020) Yutaro Yamaoka et al.   CLINICAL INFECTIOUS DISEASES

Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens

(2020) David Kim et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho

(2020) Andrew Bryan et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Detection of Nucleocapsid Antibody to SARS-CoV-2 is More Sensitive than Antibody to Spike Protein in COVID-19 Patients

(2020) Peter D Burbelo et al.   JOURNAL OF INFECTIOUS DISEASES

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

(2020) David E. Gordon et al.   NATURE

Structural basis of receptor recognition by SARS-CoV-2

(2020) Jian Shang et al.   NATURE

Cell entry mechanisms of SARS-CoV-2

(2020) Jian Shang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

(2020) Stephen M. Kissler et al.   SCIENCE

Biochemical characterization of SARS-CoV-2 nucleocapsid protein

(2020) Weihong Zeng et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

COVID-19 pathophysiology: A review

(2020) Koichi Yuki et al.   CLINICAL IMMUNOLOGY

Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by 4 automated immunoassays and 3 ELISAs

(2020) Jan Van Elslande et al.   CLINICAL MICROBIOLOGY AND INFECTION

Distinct Early Serological Signatures Track with SARS-CoV-2 Survival

(2020) Caroline Atyeo et al.   IMMUNITY

Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2

(2020) Peter Muench et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies

(2020) Kathleen G. Beavis et al.   JOURNAL OF CLINICAL VIROLOGY

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

(2020) Julian Braun et al.   NATURE

A perspective on potential antibody-dependent enhancement of SARS-CoV-2

(2020) Ann M. Arvin et al.   NATURE

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital

(2020) Alberto L. Garcia-Basteiro et al.   Nature Communications

Analytical and Clinical Evaluation of the Automated Elecsys Anti–SARS-CoV-2 Antibody Assay on the Roche cobas e602 Analyzer

(2020) Clarence W Chan et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

(2020) Gregory A Poland et al.   LANCET

SARS-CoV-2 vaccines in development

(2020) Florian Krammer   NATURE

Seasonal coronavirus protective immunity is short-lasting

(2020) Arthur W. D. Edridge et al.   NATURE MEDICINE

S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit

(2020) Phuong Nguyen-Contant et al.   mBio

A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

(2020) Angkana T. Huang et al.   Nature Communications

COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2

(2020) Anshumali Mittal et al.   PLoS Pathogens

Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies

(2020) Wen Shi Lee et al.   Nature Microbiology

Serologic testing of U.S. blood donations to identify SARS-CoV-2-reactive antibodies: December 2019-January 2020

(2020) Sridhar V Basavaraju et al.   CLINICAL INFECTIOUS DISEASES

Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19

(2020) Petra Bacher et al.   IMMUNITY

Recent endemic coronavirus infection is associated with less-severe COVID-19

(2020) Manish Sagar et al.   JOURNAL OF CLINICAL INVESTIGATION

Development and Evaluation of a Multiplexed Immunoassay for Simultaneous Detection of Serum IgG Antibodies to Six Human Coronaviruses

(2019) Suvang U. Trivedi et al.   Scientific Reports

Original antigenic sin: A comprehensive review

(2017) Anup Vatti et al.   JOURNAL OF AUTOIMMUNITY

Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses

(2016) Shuo Su et al.   TRENDS IN MICROBIOLOGY

Functional characterization and proteomic analysis of the nucleocapsid protein of porcine deltacoronavirus

(2015) Sunhee Lee et al.   VIRUS RESEARCH

The SARS coronavirus nucleocapsid protein – Forms and functions

(2014) Chung-ke Chang et al.   ANTIVIRAL RESEARCH

Serological assays for emerging coronaviruses: Challenges and pitfalls

(2014) Benjamin Meyer et al.   VIRUS RESEARCH

The Coronavirus Nucleocapsid Is a Multifunctional Protein

(2014) Ruth McBride et al.   Viruses-Basel

Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43

(2010) Hyun-Kyoung Lee et al.   Journal of Veterinary Science

Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine

(2008) Noton Kumar Dutta et al.   IMMUNOLOGY LETTERS

The Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus Inhibits Cell Cytokinesis and Proliferation by Interacting with Translation Elongation Factor 1 

(2008) B. Zhou et al.   JOURNAL OF VIROLOGY